Canadian guidelines for the initial management of adults with community-acquired pneumonia: An evidence based update by Canadian Infection Diseases Society and the Canadian Thoracic Society
Mandell L. A., Marrie T. J., Grossman R. E. Canadian guidelines for the initial management of adults with community-acquired pneumonia: an evidence based update by Canadian Infection Diseases Society and the Canadian Thoracic Society. Clin. Infect. Dis. 2000; 31: 383-421.
The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland
Kauppinen M. T., Herva E., Kujala P. et al. The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J. Infect. Dis. 1995; 172: 1330-1335.
Management of adult community-acquired lower respiratory tract infections
Huchon G., Woodhead M., Gialdroni-Grassi G. Management of adult community-acquired lower respiratory tract infections. Eur. Respir. J. 1998; 11: 986-991.
Prevalence of Chlamydia pneumonia in healthy chidren and in children with respiratory tract infections
Falk G., Gnarpe I., Gnarpe H. Prevalence of Chlamydia pneumonia in healthy chidren and in children with respiratory tract infections. Pediatr. Infect. Dis. J. 1997; 16 (6): 549-554.
Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: Effect of clarithromycin
Kraft M., Cassel G. H., Pak I., Martin R. I. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest 2002; 121 (6): 1782-1788,
Atypical pathogen infection in adults with acute exacerbation of bronchial asthma
Lieberman D., Printz S. et al. Atypical pathogen infection in adults with acute exacerbation of bronchial asthma. Am. J. Respir. Care Med. 2003; 167 (3): 406-410.